Lyka Labs Ltd. — Capital/Financing Update 2025

Feb 26, 2025

==> picture [431 x 40] intentionally omitted <==

26[th] February, 2025

BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, G. Block, Dalal Street, Bandra Kurla Complex, Bandra (East), Mumbai Mumbai 400 001 400 051

Script Code: 500259 Script Code: LYKALABS

Dear Sir/Madam,

Sub.: Credit Rating intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20 15, we wish to inform you that India Ratings & Research Pvt. Ltd. has assigned/ affirmed the rating of the bank facilities availed by the Company, as detailed below:

Instrument Type	MaturityDate	Size of Issue(million)	Rating/Outlook	RatingAction
Term loan	31stJuly2028	INR155.6 ((reducedfrom INR 175)	IND BBB+/Stable	Affirmed
Fund-based working capitalLimit*****	-	INR120	IND BBB+/Stable/IND A2	Affirmed
Term loan	31stMarch,2030	INR87.5	IND BBB+/Stable	Assigned

***** Sub limits are cash credit of INR120 million, post shipment credit of INR120 million, reshipment credit of INR120 million, working capital demand loan of INR120 million, sight letter of credit (LC) of INR3 million, import usance LC of INR5 million, local sight LC of INR50 million, local usance LC of INR50 million and bank guarantee performance of INR20 million.

Kindly take the same on your record.

Thanking You,

Yours faithfully, For Lyka Labs Limited SHEKHAR Digitally signed by SHEKHAR RAMJEET RAMJEET SINGH Date: 2025.02.26 SINGH 09:35:47 +05'30' Shekhar R Singh Company Secretary

==> picture [439 x 27] intentionally omitted <==